FDA gives 510(k) clearance for Myriad automated tissue removal technology in surgery- NICO Corporation
The U.S. FDA has granted a new and updated 510(k) clearance for the Myriad automated tissue removal technology made by NICO Corporation used in a new approach for brain surgery. NICO received a new clearance for specific neurosurgical indications on its patented Myriad automated tissue removal technology. The new clearance provides specific disease state approval for primary and secondary brain tumors, vascular abnormalities and malformations, and intraventricular tumors and cysts.
Myriad is an automated, multi-functional tool used for precise resection, suction, clot evacuation and tumor removal in neurosurgery, spinal surgery, ENT and otolaryngology. It consists of the console, handpieces and ancillary products.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
3 mins